Tryptophan Hydroxylase (Phospho-Ser²⁶⁰) Polyclonal Antibody

TPH catalyzes the 5-hydroxylation of tryptophan, which is the first step in the biosynthesis of indoleamines (serotonin and melatonin).¹ In mammals, serotonin biosynthesis occurs predominantly in neurons which originate in the Raphe nuclei of the brain, and melatonin synthesis takes place within the pineal gland. Although TPH catalyzes the same reaction within the Raphe nuclei and the pineal gland, TPH activity is rate-limiting for serotonin but not melatonin biosynthesis. Serotonin functions mainly as a neurotransmitter, whereas melatonin is the principal hormone secreted by the pineal gland. The activity of TPH is enhanced by phosphorylation by cAMP-dependent protein kinase (PKA) and Ca²⁺/calmodulin kinase II (CaM K II).^2,3 CaM K II phosphorylate Ser²⁶⁰ which lies within the regulatory domain of TPH.²

WARNING This product is not for human or veterinary use.

1. Martinez, A., Knappskog, P.M., and Haavik, J. A structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosyntheis. Curr. Med. Chem. 8(9), 1077-1091 (2001).

2. Jiang, G.C., Yohrling, G.J., Schmitt, J.D., et al. Identification of substrate orienting and phosphorylation sites within typtophan hydroxylase using homology-based molecular modeling. J. Mol. Biol. 302, 1005-1017 (2000).

3. Johansen, P.A., Jennings, I., Cotton, R.G., et al. Phosphorylation and activation of tryptophan hydroxylase by exogenous protein kinase A. J. Neurochem. 66, 817-823 (1996).